Cem Ortabaş is a Co-Founder of HubX, a technology company established in January 2016 that specializes in developing highly scalable mobile applications, with a successful portfolio reaching over 100 million users globally. In addition to this role, Cem serves as a Board Member at Urla Şarapçılık since October 2020 and as an Investor in both Biosplice Therapeutics, a biotech firm focused on regenerative medicine, and Veloxia Technology since June 2020. Cem Ortabaş holds a Bachelor of Business Administration from Koç University, completed in 2017, and is currently pursuing further education at Harvard Business School Online.